Close

Seattle Genetics Inc. (SGEN) Tops Q2 EPS by 9c

July 31, 2014 4:22 PM EDT

Seattle Genetics Inc. (NASDAQ: SGEN) reported Q2 EPS of ($0.14), $0.09 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $68.3 million versus the consensus estimate of $65.04 million.

For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings